|
Volumn 8, Issue 3, 2002, Pages 684-690
|
Phase I study of N1, N11-diethylnorspermine in patients with non-small cell lung cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
N1,N11 DIETHYLNORSPERMINE;
ABDOMINAL CRAMP;
ADULT;
AGED;
ARTICLE;
ASTHENIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSE CALCULATION;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG ACTIVITY;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LUNG NON SMALL CELL CANCER;
MALE;
NAUSEA;
PHASE 1 CLINICAL TRIAL;
POLYAMINE SYNTHESIS;
PRIORITY JOURNAL;
TUMOR GROWTH;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FEVER;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NAUSEA;
SAFETY;
SPERMINE;
VOMITING;
|
EID: 0036306242
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (81)
|
References (34)
|